SAM Advised Trichem Group On Sale Of 100% Of Its Stake To IMCD Group

July 8, 2025

Shardul Amarchand Mangaldas & Co advised Trichem Group and its Promoters in connection with the sale of 100% equity stake in Trichem Healthcare Private Limited, Trichem Lifesciences Limited, and Chemistry & Health FZ LLC (Dubai) to the IMCD Group.

This strategic acquisition marks a significant milestone for the IMCD Group as it strengthens its presence in the high-growth life sciences sector in India and the Middle East.

The deal will allow IMCD to leverage Trichem’s deep industry relationships across the globe and technical know-how and aligns with IMCD’s commitment towards sustainable value creation in the speciality chemicals and ingredients sector.

The transaction (M&A) team was led by Partner Jay Gandhi, and comprised Partner Kaustubh Verma, Senior Associates Ankit P., and Sanjana Kumar. The transaction (M&A) team was supported by the Dispute Resolution team, including Partner Shreya Jain.

Ankit P., Jay Gandhi, Kaustubh Verma, Sanjana Kumar, Shreya Jain

Mergers & Acquisitions

The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at connect@thedealmatter.com mentioning your firm’s name, lawyers involved (including designation) and client represented.